Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
Stockholm - Stockholm 即時價格。貨幣為 SEK。
加入追蹤清單
市場開市。 截至 01:55PM CEST。
正在載入互動式股價圖表...
- Zacks
All You Need to Know About Swedish Orphan Biovitrum (BIOVF) Rating Upgrade to Strong Buy
Swedish Orphan Biovitrum (BIOVF) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Benzinga
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $1.7 billion. The transaction price represents an 89% premium to CTI's closing share price on May 9, 2023, and a 95% premium to its 30-trading day volume-weighted average price of $4.67. The transaction will diversify Sobi's portfolio of hematology medicines through CTI's lead product, Von
